JAK inhibitors and VTE risk: how concerned should we be?

被引：14
|
作者：
Cohen, Stanley B. [1 ,2 ]
机构：
[1] THR Presbyterian Hosp, Metroplex Clin Res Ctr, Dept Rheumatol, Dallas, TX 75231 USA
[2] Univ Texas Southwestern Med Sch, Dallas, TX 75390 USA
来源：
NATURE REVIEWS RHEUMATOLOGY | 2021年 / 17卷 / 03期
关键词：
RHEUMATOID-ARTHRITIS; SAFETY PROFILE; THROMBOSIS;
D O I：
10.1038/s41584-021-00575-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Janus kinase (JAK) inhibitors have become standard treatment for patients with rheumatoid arthritis who do not respond well to other DMARDs. Concerns have been raised over an increased risk of venous thromboembolism with JAK inhibitors, tempering enthusiasm for their use in the clinic, but are these concerns justified?
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [1] JAK inhibitors and VTE risk: how concerned should we be?
    Stanley B. Cohen
    [J]. Nature Reviews Rheumatology, 2021, 17 : 133 - 134
  • [2] Notification of occupational disease and risk of work disability - how concerned should we be?
    Frost, Poul
    Andersen, Johan Hviid
    Thomsen, Jane Frolund
    Svendsen, Susanne Wulff
    [J]. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2013, 39 (04) : 420 - 420
  • [3] Antimicrobial resistance in hospitals: How concerned should we be?
    Mulvey, Michael R.
    Simor, Andrew E.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (04) : 408 - 415
  • [4] Hepatotoxicity induced by coxibs: how concerned should we be?
    Bessone, Fernando
    Hernandez, Nelia
    Gabriel Roma, Marcelo
    Ridruejo, Ezequiel
    Mendizabal, Manuel
    Medina-Caliz, Inmaculada
    Robles-Diaz, Mercedes
    Isabel Lucena, M.
    Andrade, Raul J.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (11) : 1463 - 1475
  • [5] Refeeding syndrome in the gastroenterology practice: how concerned should we be?
    Nunes, Goncalo
    Brito, Mariana
    Santos, Carla Adriana
    Fonseca, Jorge
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (11) : 1270 - 1276
  • [6] Gen Y learners: just how concerned should we be?
    White, Geoff
    Kiegaldie, Debra
    [J]. CLINICAL TEACHER, 2011, 8 (04): : 263 - 266
  • [7] Haemoptysis with a normal chest radiograph: how concerned should we be?
    Colice, Gene L.
    [J]. THORAX, 2009, 64 (10) : 829 - 830
  • [8] Chemotherapy-associated hepatotoxicity: how concerned should we be?
    Aloia, Thomas A.
    Fahy, Bridget N.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (04) : 521 - 527
  • [9] Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
    Tandukar, Srijan
    Fried, Linda F.
    [J]. NEPHRON, 2018, 140 (01) : 58 - 62
  • [10] RODEOS - SHOULD WE BE CONCERNED
    GETHING, M
    [J]. NEW ZEALAND VETERINARY JOURNAL, 1987, 35 (09) : 155 - 155
12345